Skip to content

BioEngLink

Active
Private limited companyfounded 20206 yrs activeDe Pintelaan 24, 9000 Gent, BelgiumKBO/BCE: BE 0750.509.487

BioEngLink has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3k and a net result of €17k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 9369 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
45 / 100
Fair▼ -28 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency15▼-9
Growth58=
Stability100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.99 against 1.12 in 2024), and 93.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 71
Relative position
BE, all sectors
reference
Sector 71
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 6 years 0 10 y
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 9369 sector peers (2025).
NBB · sector comparison
Position among 9369 sector peers
Solvency
better than 13%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 02-02-2026, 2 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filings
Deviation from the deadline
2025
2 d late
2024
5 d late
2023
on the day
2022
on the day
2021
on the day
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close12-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€3k▼ 76.1%
2024 · €13k
2021: €13k 2022: €25k 2023: €44k 2024: €13k
2021 → 2025
Total assets
€45k▼ 45.1%
2024 · €82k
2021: €37k 2022: €39k 2023: €56k 2024: €82k
2021 → 2025
Net result
€17k▼ 8.2%
2024 · €19k
2021: €10k 2022: €12k 2023: €19k 2024: €19k
2021 → 2025
Working capital
€-547
2024 · €8k
2021: €14k 2022: €20k 2023: €38k 2024: €8k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€13k-€25k▲ 87.4%€44k▲ 76.5%€13k▼ 71.2%€3k▼ 76.1%
Operating result€13k-€15k▲ 12.5%€23k▲ 59.5%€23k▼ 0.8%€21k▼ 7.8%
Net result€10k-€12k▲ 13.2%€19k▲ 64.1%€19k▲ 0.5%€17k▼ 8.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€10k€20kOperating result 2021: €13k€13kNet result 2021: €10k€10kOperating result 2022: €15k€15kNet result 2022: €12k€12kOperating result 2023: €23k€23kNet result 2023: €19k€19kOperating result 2024: €23k€23kNet result 2024: €19k€19kOperating result 2025: €21k€21kNet result 2025: €17k€17k20212022202320242025
The operating result has fallen two years in a row; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €45k
Fixed assets €4k▼ 16.4%
Current assets €41k▼ 46.9%
Equity and liabilities €45k
Equity €3k▼ 76.1%
Debt €42k▼ 39.5%
The debt ratio rises from 84.6% to 93.3%: equity shrinks faster than debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€22k
2024 · €24k
Cash flow
€18k
2024 · €20k
Solvency
6.7%
2024 · 15.4%
Current ratio
0.99
2024 · 1.12
Quick ratio
0.99
2024 · 1.12
Debt / equity
13.92
2024 · 5.49
ROE
581.1%
2024 · 151.1%
ROA
39.0%
2024 · 23.3%
Interest coverage
103.06
2024 · 238.89
Debt
€42k
2024 · €69k
Debt ≤ 1 year
€41k
2024 · €69k
Income taxes
€5k
2024 · €5k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€82k€45k
Fixed assets21/28€5k€4k
Tangible fixed assets22/27€5k€4k
Plant, machinery and equipment23€226€106
Furniture and vehicles24€509€379
Other tangible fixed assets26€4k€4k
Current assets29/58€77k€41k
Amounts receivable within one year40/41€36k€8k
Trade receivables40€11k€3k
Other amounts receivable41€25k€5k
Cash at bank and in hand54/58€40k€31k
Deferred charges and accrued income490/1€1k€1k
Equity and liabilities
Total equity and liabilities10/49€82k€45k
Equity10/15€13k€3k
Contributions10/11€3k€3k=
Reserves13€300-
Distributable reserves133€300-
Profit (loss) carried forward14€9k-
Amounts payable17/49€69k€42k
Amounts payable within one year42/48€69k€41k
Trade debts44€3k€3k
Suppliers440/4€3k€3k
Taxes, remuneration and social security45€23k€16k
Taxes450/3€23k€16k
Other amounts payable47/48€43k€23k
Accrued charges and deferred income492/3€500€500=
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€794€794=
Other operating charges640/8€580€738
Gross operating margin9900€25k€23k
Operating profit (loss)9901€23k€21k
Financial income75/76B€1k€1k
Recurring financial income75€1k€1k
Financial charges65/66B€101€216
Recurring financial charges65€101€216
Profit (loss) for the period before taxes9903€24k€23k
Income taxes67/77€5k€5k
Profit (loss) for the period9904€19k€17k
Profit (loss) for the period to be appropriated9905€19k€17k
Appropriation of the result
Profit (loss) to be appropriated9906€59k€27k
Profit (loss) brought forward from the previous period14P€40k€9k
Transfer from equity791/2-€300
Profit to be distributed694/7€50k€27k
Return on contributions (dividend)694€50k€27k

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
02-02
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 2 days late
2025
05-02
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 5 days late
2024
30-06
Financial Highest result since 2021net €19k ▲0.5%
Net result €19k, the highest in the series.
31-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-01
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-01
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2020
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

De Pintelaan 249000 Gent
Ground area
59 m²
Building footprint
39 m²
Volume, LiDAR
279 m³
Parcel 44808H0202/00F004, Flanders · tallest building 9.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
BioEngLink
De Pintelaan 24, 9000 GentIT consultancy
since 20202.304.664.372
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44808H0202/00F004 Flanders 59 m² 1 · 39 m² 9.4 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 11,503 companies in sector 71121 we hold annual accounts for 6,523. 1,322 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded10-07-2020
Fiscal year end30-06
Activities, NACEBEL
71121Engineering and related technical consultancy, excluding land surveyors
33200Installation of industrial machinery and equipment
62020IT consultancy
62200Computer consultancy and computer facilities management
70200Business and other management consultancy
70220Business consulting
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Data from official sources, last processed on 11-09-2026. Scores and ratios are computed by Checked and are not a credit decision.